Q2 2021 10-Q

Company

Finch Therapeutics Group, Inc.

Filed

August 10, 2021

Period of Report

June 30, 2021

Accession Number

0001564590-21-043094

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →